| Alice-Maria Toader | Embedding randomised trials within routine care | University of Liverpool |
| Azar Alexander-Sefre | Making it easier for trial teams to design inclusive trials | University of Aberdeen |
| Faye Baldwin | Emulating biomarker-guided target trials using big data | University of Liverpool |
| Felicity Spencer | OPTI-EX: Optimising exercise interventions for people at risk of dementia | University of Birmingham |
| Georgiana Synesi | Increasing representation of under-served groups in randomised oncology trials | Institute of Cancer Research |
| Henry Bern | Advancing the development of the DURATIONS design in practice | University College London |
| Jerome Johnson | Using observational data and/or single arm studies to inform trial design: can we make our trials smaller and shorter? | University College London |
| Ryan McChrystal | Predictors of early trial termination using individual-level participant data and aggregate-level data from multiple trials | University of Glasgow |
| Sophie Greenwood | Eliciting and incorporating patient’s opinions about missing data in randomised controlled trials | University of Aberdeen |
| Susannah Cowtan | Assessing the feasibility of complex and innovative trial designs | University of Leeds |
| Hadeel Hussein | Handling multiple outcomes in randomised trials | University of Glasgow |
| Kate Roberts | Consent to access and use routine health data: appropriate wording for participant-facing materials of randomised clinical trials (CrossWord) | University College London |
| Ella Howes | Remote delivery of complex interventions within trials: understanding and applying knowledge from COVID-19 adaptations to guide future delivery, inclusivity and tailoring of trial interventions | University of Leeds |
| Frank You | Changing behaviour to enable design and delivery of low carbon trials? | University of Aberdeen |
| Zhi Cao | Seamless phase I/II adaptive designs for precision medicine trials | University of Cambridge |
| Victoria Githu | Improving the Design of Vector Control Trials | University of Glasgow |
| Raiann Hamshaw | Unbiased Estimation in Hierarchical Models for Clinical Trials | Newcastle University |
| Luke Evans | Agile development methodology of matched synthetic control for Bayesian trials in the era of genomic medicine | Institute of Cancer Research |
| Yuanjin Zhang | Statistical methods for economic evaluation alongside stepped wedge cluster randomised controlled trial | Queen Mary University London |
| Jack Hall | Covariate adjustment in cluster randomised trials with binary outcomes focussing on relative risks and risk difference. | Birmingham |
| Isaac Egesa | Using existing data to optimise adaptive interventions in epilepsy | University of Liverpool |
| Nicole Cizauskas | (iCASE Project) Improving the development and use of synthetic data for clinical trials | Newcastle University |
| Non Davies | Defining outcome measures for medication adherence in clinical trials | Bangor University |
| Rebecca Petty | Promoting Parkinson’s disease trial participation in rural and coastal communities | University of Plymouth |
mrctmrpdtp.com 